Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin for treating substance use disorders?

de Veen BT, Schellekens AF, Verheij MM, Homberg JR

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (12)

    1. The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus 2026-05-07 · Expand citations
    2. Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey 2026-04-15 · Expand citations
    3. Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency 2025-12-11 · Expand citations
    4. Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review 2025-05-02 · Expand citations
    5. Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications 2024-11-30 · Expand citations
    6. Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence 2024-07-04 · Expand citations
    7. Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling 2023-03-01 · Expand citations
    8. The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review 2023-01-05 · Expand citations
    9. Psilocybin administration 2022-08-02 · Expand citations
    10. Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current research 2022-06-22 · Expand citations
    11. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin 2021-01-01 · Expand citations
    12. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance 2017-01-02 · Expand citations